Experts Explain Impact of Trastuzumab Deruxtecan Approval in HER2+ Breast Cancer
Faculty voice their opinion on the clinical utility of trastuzumab deruxtecan in patients with metastatic HER2-positive breast cancer.
Source: OncLive
BREAKING NEWS: Herbal Works Inc. Continues Social Media Marketing Campaign with Launch of YouTube Channel

